A randomised control trial of BIC/F/TAF vs DRV/c/F/TAF in context of HIV test-and-treat, BicTnT

A randomised control trial of BIC/F/TAF vs DRV/c/F/TAF in context of HIV test-and-treat, BicTnT

Background Head-to-head data for bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF; B) and darunavir/cobicistat/emtricitabine/tenofovir alafenamide (DRV/c/F/TAF; D) are lacking in the context of rapid antiretroviral therapy (ART) initiation. This study, BIC-T&T, evaluates the efficacy a...

Full description

Saved in:
Bibliographic Details
Main Authors: Gary Whitlock, Sarah Fidler, Amanda Clarke, Sujin Kang, Arnold Xhikola, Ana Milinkovic, Alfredo Soler-Carracedo, Merle Henderson, Tanya Adams, Ishrat Jahan, Akif Khawaja, Graham Taylor, Marta Boffito
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:HIV Research & Clinical Practice
Subjects:
drv/c/f/taf
bic/ftc/taf
hiv infection
rapid art strategy
test-and-treat
Online Access:http://dx.doi.org/10.1080/25787489.2024.2400453
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://dx.doi.org/10.1080/25787489.2024.2400453

Similar Items